Tobacco Institute
Editorial: Preventive Oncology and the National Cancer Program ["Editorial: Preventive Oncology and the National Cancer Program".]
Fields
- Alias
- TIMN-0114788-0114812
- T118731-T118733 0043-1550
- Type
- PUBLISHED DOC
- Site
- Wynder Cipollone: Wynder Files
- Named Person
- Ahf Marketing 1
- Nih 2
- Surgeon General
- Lemaistre, C.
- Wynder, E.L.
- Berlin, N.
- Breslow, L.
- Carter, S.
- Newell, G.
- Selikoff, I.
- Upton, A.
- Weinstein, B.
- Weissburger, J.
- Devita, V.
- Lederberg, J.
- Breslow, L.
- Nih 2
- Request
- Mn1-73
- Mn1-94
- Date Loaded
- 05 Jun 1998
- Characteristic
- MARGINALIA
- Author
- Preventive Medicine 3
- Wynder, E.L. 4
- Lemaistre, C. 5
- Wynder, E.L. 4
- Litigation
- Minnesota AG
- Box
- 047
- UCSF Legacy ID
- toi92f00
Annotations
- 1. Ahf Marketing Named Person
- Affiliation:
Ahf Marketing
- Affiliation:
- 2. Nih Named Person
- Affiliation:
NIH
- Affiliation:
- 3. Preventive Medicine Author
- Affiliation:
Preventive Medicine
- Affiliation:
- 4. Wynder, E.L. Author
- Affiliation:
Ahf
- Affiliation:
- 5. Lemaistre, C. Author
- Affiliation:
University Texas
- Affiliation:
Document Images
~
A C
~~~~_ P~sl Ne~
Editorial: Preventive Oncology and the Nx*~
National Cancer Program'2
PREVENTIVE MEDICINE 9l823-825 (t980)/vQ&
lIY
CHAIRMEN
xCHARLES LEMAISTRE , ERNST L. WYNDER
President President
University of Texas System Cancer Center American Health Foundation
PARTICIPANTS
1~( NATHAN BERLIN
Director
Cancer Center
Northwestern University
~( IRVING SELIKOFF
Professor of Medicine and Community Medicine and Director
Environmental Science Lab
Mt. Sinai School of Medicine
}( LESTER BRESLOW
Dean
School of Public Health
University of California at Los Angele"s
STEPHEN CARTER
Noxhern California Center Program
~r Guy NEWELL
/` Director
Office of Cancer Prevention
University of Texas System Cancer Center
x ARTHUR UPTON
Professor and Chairman
Department of Environmental Medicine
New York University
BERNARD WEINSTEIN
~irector of Environmental Sciences
Columbia University
)<- JOHN WEISBURGER
Vice President for Research
Naylor Dana Institute
American Health Foundation
,
DEFINING CANCER PREVENTION
Cancer prevention is the reduction of the occurrence of cancer by identifying
causes and developing measures to remove or counteract them.
STATE OF THE ART
Epidemiological study has disclosed identifiable causes for a significant propor-
tion of human cancers, and there has long been a serious financial and professional
commitment to uncovering the causes and mechanisms of carcinogenesis. Some
' In Apri11980, a group of scientists met with the American Health Foundation Staff and Dr. Vincent
DeVita, the Acting Director of the National Cancer Institute, to define preventive oncology and how
preventive oncology could best evolve with the National Cancer Program. An additional participant in
the afternoon session of the conference was Dr. Joshua Lederberg, President of Rockefeller Univer-
sity. As part of this conference, Dr. DeVita outlined the role of preventive oncology within the
program of NCL The present communication has had the input of the above participants as well as
Lester Breslow, who could not personally be with us.
g Sponsored by the American Health Foundation, 320 East 43rd Street, New York, N.Y. 10017,
April 14, 1980.
' To whom requests for reprints should be addressed.
823
TIMN 0114788
0091-7435/80/060823-03502.00/0
Copytigl# Q 1980 by Academic Press. Ieo.
All rishts of mpmductioa in any form reserved.
T-1
,
:C

may argue that any investigation of the mechanism of any disease is ultimately
preventive in nature. History, however, has repeatedly shown that the prevention
of certain diseases, including certain cancers, is not necessarily contingent on
deciphering the precise mechanism by which a given agent initiates cancer or a
cell defends itself. While there has been much verbal emphasis on the ultimate
potential of cancer prevention, a relatively small proportion of the total National
Cancer Program budget is devoted to, and consequently relatively few inves-
tigators are involved with, the exploitation of existing knowledge for cancer pre-
vention.
PROBLEMS OF CANCER PREVENTION
Several factors underlie our failure to advance preventive oncology adequately.
Preventive medicine of any kind plays a limited role in medical school training,
and it receives little more than lip service from the medical care providers, espe-
cially hospitals. It would appear that in medicine, as in politics, we tend to be
crisis oriented. This general neglect for preventive medicine by the medical estab-
lishment and society is reflected in the priorities within the National Institutes of
Health.
This state of affairs is not, however, irreversible. If the leadership of the Na-
tional Cancer Program would place greater emphasis on cancer prevention, and if
its disciplines could be ihterrelated and enhanced within a given institution, the
pace and success rate of cancer prevention could be accelerated.
SMOKING AND CANCER AS EXAMPLES ^
Tobacco-related cancers may serve as an example. It is universally agreed that
tobacco-related cancers are, in principle, among the most preventable types of
cancers. Although a yearly Surgeon General's Report on Smoking and Health is
issued, few organized programs implement the knowledge already available.
There is presently no working group on Smoking and Health at NCI. There are
no study sections intended for proposals specifically in this area or that suggest
new fields of research. Yet, we can coordinate major national efforts for a class-
room health education project to prevent children from beginning to smoke; we
can promote smoking cessation programs at the workplace and in the community;
we can accelerate efforts to pinpoint the harmful agents in tobacco smoke so that
they can be removed; and we can interrelate epidemiologic capabilities to monitor
the effect of the so-called "less harmful cigarettes" on the risk of cancer and other
tobacco-related diseases. Decisive implementation of such programs would have a
major impact on tobacco-related cancers in the future.
Similar coordinated programs, in occupational and in nutritional car-
cinogenesis, could significantly advance our knowledge of the origin and potential
prevention of several types of neoplastic diseases.
Estimates of the percentages of cancers related to environmental causes have
ranged from 50 to 90%. Whatever the specific percentage, it is large. We know
through studies of the distribution of cancer throughout the world that cancer is
not an inevitable consequence of aging. Since most investigators in oncology seem
TV4N 0114789
T~.~.~ t 3fv
to sup,
detern
It is
tion, l:
nity a
nature
syster
tently
cally i
ventic
deterr
maxir
cance
multic
The
effort
I.
epide
strent
resea
pertis
2.
ter st
enabl
tion.
in ca
cial s
3.
lishec
revie
Ca
incid
tality
goals
succe
orgar
progr

r
EDITORIAL 825
ftimately
evention
igent on
icer or a
ultimate
National
w inves-
ncer pre-
to support this concept, the question remains: why do we not act upon it and, if we
determine to.,act, how can we best undertake such action?
~ ' FUTURE DIRECTIONS
It is evident that the current small and piecemeal approach to cancer preven-
tion, both within the National Cancer Institute and scientific and medical commu-
nity at large, has had very limited success. Much has been learned about the
nature of the carcinogenic process at the molecular level. This has, in turn, yielded
systems for the detection of'carcinogens. But this new knowledge is not consis-
tently and deliberately applied to the mechanisms of cancer causation for numeri-
cally important cancers, thus leading to their possible prevention. If cancer pre-
equately. vention is to play an important part in our total national cancer effort, we must
training, determine how best to design and put in place a unified program to bring about the
zrs, espe- maximum possible benefit. Accordingly, we recommend that the framework of
-nd to be cancer prevention be materially strengthened by the establishment of several
cal estab- multidisciplinary cancer prevention programs in appropriate institutional settings.
stitutes of The following general guidelines are recommended for coordinating preventive
efforts in research and education with the goal of the elimination of cancer:
~f the Na- 1. A multidisciplinary cancer prevention program should include activities in
on, and if epidemiology, metabolic epidemiology, and health education. It would be
ution, the strengthened (although this is not essential) by the additional ability to conduct
research in experimental carcinogenesis. Several institutions could pool their ex-
pertise into a multidisciplinary cancer prevention program.
2. Such a multidisciplinary cancer prevention program at an institution or cen-
.greed that ter should be in the position to apply for a cancer prevention CORE grant, thus
e types of enabling the center to attract candidates of the highest calibre into cancer preven-
I Health is tion. It is particularly important that some sense of long-term financial continuity
ilable. in cancer prevention be provided, since prevention centers cannot rely on finan-
There are cial support from patients, as can clinical centers.
iat suggest 3. An appropriate organizational division for such programs should be estab-
7or a class- lished within the NCI, along with appropriate extramural advisory and peer-
smoke: we review groups.
ammunity; Cancer prevention has two readily measured end points, the reduction of the
)ke so that incidence of cancer and, through early detection of cancer, the reduction in mor-
to monitor ~ tality. All of our activities must be directed toward the swift achievement of these
r and other goals. Those involved in cancer prevention are optimistic about our opportunity to
)uld have a 1 succeed but we recognize that to realize these opportunities we should ideally
organize our efforts within the framework of multidisciplinary cancer prevention
ional car- I programs.
.d potential ERNST L. WYNDER
auses have
We know
it cancer is
ology seem
'1'IIVIIV 0114790
